6533b86ffe1ef96bd12cd331

RESEARCH PRODUCT

Coronary chronic total occlusions and mortality in patients with ventricular tachyarrhythmias.

Christel WeißKambis MashayekhiSiegfried LangHans NeuserThomas ReicheltEmmanouil S. BrilakisMarouane BoukhrisGabriel TatonMartin BorggrefeArmin BollowLinda ReiserPhilipp KucheIbrahim El-battrawyNiko EngelkeAlfredo R. GalassiChristoph A. NienaberDominik EllguthTobias SchuppMichael BehnesLorenzo AzzaliniIbrahim AkinFranz-joseph Neumann

subject

Tachycardiamedicine.medical_specialtymedicine.medical_treatment030204 cardiovascular system & hematologyCoronary AngiographyCoronary artery disease03 medical and health sciences0302 clinical medicinePercutaneous Coronary InterventionRetrospective StudieRisk FactorsInternal medicinemedicineClinical endpointHumans030212 general & internal medicineMyocardial infarctionRisk stratificationRetrospective Studiesbusiness.industryMortality ratePercutaneous coronary interventionRetrospective cohort studymedicine.diseaseDeathTreatment OutcomeCoronary OcclusionCoronary occlusionCoronary chronic total occlusionChronic DiseaseCardiologyTachycardia Ventricularmedicine.symptomCardiology and Cardiovascular Medicinebusiness

description

Aims This study sought to assess the prognostic impact of coronary chronic total occlusions (CTO) in patients presenting with ventricular tachyarrhythmias on admission. Methods and results A large retrospective registry was used, including all consecutive patients presenting with ventricular tachyarrhythmias on admission and undergoing coronary angiography from 2002 to 2016. Patients with a CTO were compared with all other patients (non-CTO) for prognostic outcomes. Statistics comprised Kaplan-Meier and Cox regression analyses. Within a total of 1,461 consecutive patients included with ventricular tachyarrhythmias on admission, a CTO was present in 20%. At midterm follow-up of 18 months, the primary endpoint all-cause mortality had occurred in 40% of CTO patients compared to 27% of non-CTO patients (HR 1.563, 95% CI: 1.263-1.934; p=0.001). The rates of secondary endpoints were higher for in-hospital all-cause mortality at index (29% versus 20%, log-rank p=0.027) and the composite endpoint of cardiac death at 24 hours, recurrent ventricular tachyarrhythmias and appropriate ICD therapies at midterm follow-up (28% versus 20%, log-rank p=0.005). Mortality rates were highest in CTO patients with stable coronary artery disease (CAD), acute myocardial infarction and in patients surviving index hospitalisation. Conclusions In patients presenting with ventricular tachyarrhythmias on admission, the presence of a coronary CTO is independently associated with an increase of midterm all-cause mortality, in-hospital all-cause mortality and the composite endpoint of early cardiac death, recurrent ventricular tachyarrhythmias and appropriate ICD therapies.

10.4244/eij-d-18-00496https://pubmed.ncbi.nlm.nih.gov/30666964